AMY MERKEL: Open Payments
NPI 1174340392 · WINFIELD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$941 in 29 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $24 · 2025 $941
Food & beverage: $941
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $300 |
| SCPHARMACEUTICALS INC. | 3 | $180 |
| Novartis Pharmaceuticals Corporation | 4 | $119 |
| AstraZeneca Pharmaceuticals LP | 5 | $106 |
| Merck Sharp & Dohme LLC | 4 | $76 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $53 |
| Esperion Therapeutics, Inc. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Mannkind Corporation | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: JARDIANCE, FUROSCIX, LEQVIO, VERQUVO, LifeVest, FARXIGA, NEXLETOL, WAINUA.
Industry payments across IL — which companies pay providers there.
